Omeprazol Punkt (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Punkt, is a proton pump inhibitor presented as a strength/form for oral use. It reduces stomach acid production and is used to treat gastro‑reflux disease and related conditions in adults and children. GNH USA supplies Omeprazol Punkt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omeprazol Punkt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related disorders.

- Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Peptic ulcer disease: supports ulcer healing by maintaining a less acidic gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with the condition. - Erosive esophagitis: aids healing of erosive lesions in the esophagus. - Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Abdominal pain or discomfort. - Nausea or vomiting. - Flatulence or bloating. - Constipation.

Serious or Rare Side Effects: - Clostridioides difficile‑associated colitis. - Acute interstitial nephritis. - Severe allergic reactions such as anaphylaxis. - Low magnesium levels (hypomagnesemia). - Fracture risk with long‑term use. - Vitamin B12 deficiency with prolonged therapy.

When using Omeprazol Punkt, consider the following safety measures:

- Assess renal function: adjust use in severe impairment. - Review hepatic status: use with caution in liver disease. - Evaluate need for long‑term therapy: monitor for bone density loss. - Monitor electrolytes: watch for low magnesium during extended treatment. - Pregnancy and lactation: use only if clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Omeprazole may affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Atorvastatin: increased exposure, higher risk of myopathy. - Methotrexate: elevated levels, potential toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: altered absorption, check serum levels. - HIV protease inhibitors (e.g., ritonavir): reduced efficacy, adjust dosing if needed.